المؤلفون: Güdemann, Laura M., Young, Katie G., Thomas, Nicholas J.M., Hopkins, Rhian, Challen, Robert, Jones, Angus G., Hattersley, Andrew T., Pearson, Ewan R., Shields, Beverley M., Bowden, Jack, Dennis, John M., McGovern, Andrew P.

المصدر: Güdemann , L M , Young , K G , Thomas , N J M , Hopkins , R , Challen , R , Jones , A G , Hattersley , A T , Pearson , E R , Shields , B M , Bowden , J , Dennis , J M , McGovern , A P & MASTERMIND consortium 2024 , ' Safety and effectiveness of SGLT2 inhibitors in a UK population with type 2 diabetes and aged over 70 years : an instrumental variable approach ' , Diabetologia , vol. 67 , no. 9 , pp. 1817-1827 ....

مصطلحات موضوعية: Causal analysis, Effectiveness, Older adults, Safety, SGLT2 inhibitors, /dk/atira/pure/subjectarea/asjc/2700/2724, name=Internal Medicine, /dk/atira/pure/subjectarea/asjc/2700/2712, name=Endocrinology, Diabetes and Metabolism

وصف الملف: application/pdf

الاتاحة: https://discovery.dundee.ac.uk/en/publications/9938e35e-6111-4828-a7d9-70b9bdf1ea09
https://doi.org/10.1007/s00125-024-06190-9
https://discovery.dundee.ac.uk/ws/files/138736511/s00125-024-06190-9.pdf
http://www.scopus.com/inward/record.url?scp=85195273123&partnerID=8YFLogxK

المؤلفون: Cardoso, Pedro, Young, Katie G., Nair, Anand T. N., Hopkins, Rhian, McGovern, Andrew P., Haider, Eram, Karunaratne, Piyumanga, Donnelly, Louise, Mateen, Bilal A., Sattar, Naveed, Holman, Rury R., Bowden, Jack, Hattersley, Andrew T., Pearson, Ewan R., Jones, Angus G., Shields, Beverley M., McKinley, Trevelyan J., Dennis, John M.

المصدر: Cardoso , P , Young , K G , Nair , A T N , Hopkins , R , McGovern , A P , Haider , E , Karunaratne , P , Donnelly , L , Mateen , B A , Sattar , N , Holman , R R , Bowden , J , Hattersley , A T , Pearson , E R , Jones , A G , Shields , B M , McKinley , T J , Dennis , J M & MASTERMIND consortium 2024 , ' Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists ....

مصطلحات موضوعية: Bayesian non-parametric modelling, GLP1-receptor agonists, Heterogeneous treatment effects, Precision medicine, SGLT2-inhibitors, Type 2 diabetes, /dk/atira/pure/subjectarea/asjc/2700/2724, name=Internal Medicine, /dk/atira/pure/subjectarea/asjc/2700/2712, name=Endocrinology, Diabetes and Metabolism

وصف الملف: application/pdf

الاتاحة: https://discovery.dundee.ac.uk/en/publications/2187473d-7291-4b8b-a0d1-68048c13a741
https://doi.org/10.1007/s00125-024-06099-3
https://discovery.dundee.ac.uk/ws/files/121574140/s00125-024-06099-3.pdf
http://www.scopus.com/inward/record.url?scp=85185478893&partnerID=8YFLogxK

المؤلفون: Güdemann, Laura M., Young, Katie G., Thomas, Nicholas J. M., Hopkins, Rhian, Challen, Robert, Jones, Angus G., Hattersley, Andrew T., Pearson, Ewan R., Shields, Beverley M., Bowden, Jack, Dennis, John M., McGovern, Andrew P.

المصدر: Diabetologia; Sep2024, Vol. 67 Issue 9, p1817-1827, 11p

المؤلفون: Cardoso, Pedro¹ (AUTHOR), Young, Katie G.¹ (AUTHOR), Hattersley, Andrew T.¹ (AUTHOR), Shields, Beverley M.¹ (AUTHOR), Jones, Angus G.¹ (AUTHOR), Dennis, John M.¹ (AUTHOR) j.dennis@exeter.ac.uk

المصدر: Diabetes Care. Sep2024, Vol. 47 Issue 9, pe70-e71. 2p.

مصطلحات موضوعية: *GLUCAGON-like peptide 1, *TREATMENT effect heterogeneity, *SODIUM-glucose cotransporter 2 inhibitors, *TYPE 2 diabetes, *CD26 antigen